Characteristics of primary MDS with GATA2 deficiency in a consecutive population-based cohort
. | Parameter . | GATA2mut (N = 28) . | GATA2WT (N = 398) . | P value . |
---|---|---|---|---|
Mutations | Total/distinct | 28/24 | 0 | |
Age | Median (range), years | 12.3 (5.2-17.4) | 10.3 (0.2-18.1) | <.05 |
Sex | Males, N = 248 | 15 (54%) | 233 (58%) | n.s. |
Females, N = 178 | 13 (46%) | 165 (42%) | ||
Subtype | RCC, N = 341 | 15 (54%) | 326 (82%) | <.01 |
RAEB/RAEB-t, N = 85 | 13 (46%) | 72 (18%) | ||
Karyotype* | Monosomy 7,† N = 54 | 19 (70%) | 35 (11%) | <.01 |
Structural complex, N = 9 | 0 (0%) | 9 (3%) | ||
Other, N = 30 | 1 (4%)‡ | 29 (9%) | ||
Normal, N = 253 | 7 (26%) | 246 (77%) | ||
Familial disease | Index patients (%) | 8 (29%) | 8 (2%) | <.01 |
. | Parameter . | GATA2mut (N = 28) . | GATA2WT (N = 398) . | P value . |
---|---|---|---|---|
Mutations | Total/distinct | 28/24 | 0 | |
Age | Median (range), years | 12.3 (5.2-17.4) | 10.3 (0.2-18.1) | <.05 |
Sex | Males, N = 248 | 15 (54%) | 233 (58%) | n.s. |
Females, N = 178 | 13 (46%) | 165 (42%) | ||
Subtype | RCC, N = 341 | 15 (54%) | 326 (82%) | <.01 |
RAEB/RAEB-t, N = 85 | 13 (46%) | 72 (18%) | ||
Karyotype* | Monosomy 7,† N = 54 | 19 (70%) | 35 (11%) | <.01 |
Structural complex, N = 9 | 0 (0%) | 9 (3%) | ||
Other, N = 30 | 1 (4%)‡ | 29 (9%) | ||
Normal, N = 253 | 7 (26%) | 246 (77%) | ||
Familial disease | Index patients (%) | 8 (29%) | 8 (2%) | <.01 |